|Bid||35.59 x 800|
|Ask||35.60 x 800|
|Day's Range||35.00 - 39.70|
|52 Week Range||7.41 - 61.59|
|Beta (5Y Monthly)||2.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.60|
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will present at the Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021 at 10:40 a.m. Eastern / 7:40 a.m. Pacific.
The past 12 months have been a wild ride for the genetic testing company's stock, with a sub-$10 low and a high of more than $60.
What happened Shares of Invitae (NYSE: NVTA) had fallen 6.6% as of 3:13 p.m. EST on Wednesday. The medical genetics company didn't announce any news that would cause the stock to drop. Instead, Invitae's decline today appears to be part of a broader sell-off of high-growth stocks, with the Nasdaq Composite Index falling 2%.